Incidence and Prevalence of Neuroendocrine Tumors in England
Introduction: Historically the incidence and prevalence of neuroendocrine tumours (NETs) has been difficult to establish. Studies by Ellis et al in 2006 estimated the incidence of gastroenteropancreatic neuroendocrine tumours (GEP NETs) to be 1.3 per 100,000 per year (incidence hereafter given as cases per 100,000). However, the SEER USA data suggests a four-fold higher incidence, and prevalence of 35 per 100,000.
Aim(s): This study aimed to determine the incidence and prevalence of NETs in England.
Materials and methods: Age-standardised incidence rates and prevalence from the 1st January 1995 to 31st March 2016 were calculated using data from the Public Health England (PHE) National Cancer Registration and Analysis Service (NCRAS) population-based cancer registry.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Genus T
To read the full abstract, please log into your ENETS Member account.